Hematocrit modulation through needle assisted jet injection of testosterone
US11160751B2 · kind B2 · utility
0Cited by
2References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 7, 2014 |
| Grant date | Nov 2, 2021 |
| Priority date | — |
| Expiry date | Oct 7, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P15/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.